Conferences  >  Medicine & Healthcare  >  Endocrinology  >  Any Location (virtual event)

Harvard Medical School

This highly rated Harvard Medical School CME course offers practical strategies to address the medical and systemic challenges to optimal care and updates that ensure you can deliver state-of-the-art care for your patients with diabetes. This program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care. It also provides comprehensive education to optimize the diabetes care you provide for diverse patient populations, such as racial and ethnic minorities, the elderly, children and adolescents, patients with low adherence to therapy, patients at low socio-economic levels, patients with low health literacy/education, patients with depression/emotional distress, patients with diabetes and obesity, and patients with metabolic liver disease.

Harvard Medical School Postgraduate Medical Education;     Email: CEPrograms@hms.harvard.edu

Harvard, CME, diabetes, pharmacotherapy, lifestyle, special populations, treatment, prevention, nutrition, exercise, research, motivation, barriers, healthcare system, sociological, economic, updates, obesity, racial, ethnic, socioeconomic, comorbidity, medication, depression, adherence, underserved, endocrinology

Continuing Medical Education (CME),    Medicine (in general), Internal medicine

Harvard Medical School

This highly rated Harvard Medical School CME course delivers practical strategies to optimize the management of obesity and its many complications, and provides the most up-to-date approaches to obesity prevention and treatment. Presented by authorities in medicine, surgery, pediatrics, nutrition, endocrinology, gastroenterology and psychology from the country’s leading obesity treatment centers, this course covers critical topics in the prevention and treatment of obesity and related disorders. In addition, one day prior to the start of Treating Obesity 2025, we host a one-day review for the American Board of Obesity Medicine (ABOM) certification examination. This course is taught by recent diplomates of the ABOM. Participation in both Treating Obesity 2025 and the Obesity Medicine Board Review fully satisfies the CME requirement to register for the ABOM certification exam. Discounts apply when attending both the Board Review and Treating Obesity 2025.

Harvard Medical School Postgraduate Medical Education;     Email: learn@hms.harvard.edu

Harvard, CME, obesity, treatment, prevention, evaluation, surgical, medical, nutrition, lifestyle medicine, diabetes, bariatrics, pharmacology, behavioral medicine, communication, board review, genetics, precision medicine, metabolism, metabolic disorders, counseling, Obesity Medicine, ABOM, eating disorders, microbiome, GLP-1, bias, equity, stigma

Gastroenterology,    Continuing Medical Education (CME)

Harvard Medical School

This comprehensive Harvard Medical School CME program, which is among the highest-rated HMS CME courses, provides education and updates to optimize your care of patients with diabetes and these conditions: Obesity, Cardiovascular Disease, Heart Failure, Coronary Artery Disease, Hypertension, Hyperglycemia, Hypoglycemia, Dyslipidemia, Metabolic-Associated Steatotic Liver Disease, Sleep Disorders, and Chronic Kidney Disease. Sessions are led by experts in these conditions and their impact on the patient with diabetes. In addition to their clinical expertise, faculty have been chosen for their inspirational teaching skills and their ability to provide specific recommendations to incorporate the vast number of recent updates covered in this program into day-to-day clinical practice.

Harvard Medical School Postgraduate Medical Education;     Email: learn@hms.harvard.edu

Harvard, CME, diabetes, Obesity, Cardiovascular Disease, Heart Failure, Coronary Artery Disease, Hypertension, Hyperglycemia, Hypoglycemia, Dyslipidemia, Metabolic-Associated Steatotic Liver Disease, Chronic Kidney Disease, Sleep Disorders, Diabetic CKD, GLP-1 RA, SGLT-2 inhibitors, MRA, lifestyle, technology, monitors, insulin